Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247258103> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4247258103 endingPage "114" @default.
- W4247258103 startingPage "114" @default.
- W4247258103 abstract "Intravaginal progesterone (P4) releasing devices are widely used in hormonal protocols for fixed-time artificial insemination (FTAI). To reduce production cost in Brazilian farms, after first use these devices are currently reused once or twice, providing good reproductive efficiency in cattle. The aim of this study was to compare P4 plasma concentrations among time in ovariectomized cows receiving 3 different commercially available devices: Sincrogest® (SIN, 1 g of P4), Cronipres® (CRO, 1 g of P4 and 3 rings of 0,1 g of P4 for the third use) and Primer® (PRI, 1 g of P4). For each type, new (1st use, n = 2), once-used (2nd use, n = 2) and twice-used (3rd use, n = 2) devices were tested. Blood samples were collected at times 0 (before device insertion), 2, 4, 8, 10, 12, 24, 48, 72, 96, 120, 144, 168, and 192 h (Day 0 to Day 8). P4 plasma concentrations were measured by radioimmunoassay and the averages for each experimental group were submitted to analysis of variance adding repeated-measures in time factor. Comparisons were made among 3 types of device in each of 3 uses. P4 concentrations (ng mL–1) and standard deviation in the periods in which there was statistical difference (P < 0.05; a,b,cdifferent letters in the same period differ statistically) were as follows: First use: the 3 brands did not differ during the test and in Day 8 P4 levels remained near 2 ng mL–1. Second use: 2 h – SIN (3.7 ± 0.8)ab, CRO (5.4 ± 0.4)a, PRI (3 ± 0.4)b; 6 h – SIN (4 ± 0.5)a, CRO (4.9 ± 0.2)a, PRI (2.9 ± 0.3)b; and 144 h – SIN (2.2 ± 0.4)b, CRO (0.8 ± 0.3)a, PRI (1.3 ± 0.1)ab. On Day 8, Primer® and Sincrogest® P4 levels remained between 1 and 2 ng mL–1, whereas Cronipres® levels remained below 1 ng mL–1. Third use: 2 h – SIN (3.2 ± 0.04)b, CRO (7.9 ± 0.5)a, PRI (2.4 ± 0.2)b; 4 h – SIN (2.4 ± 0.4)b, CRO (5.4 ± 0.2)a, PRI (2.8 ± 0.3)b; 6 h – SIN (2.5 ± 0.8)b, CRO (7.4 ± 1.8)a, PRI (2.7 ± 0.5)b; 8 h – SIN (2.3 ± 0.2)b, CRO (5.3 ± 1.4)a, PRI (2 ± 0.1)b; 10 h – SIN (3.1 ± 0.2)b, CRO (5.5 ± 0.5)a, PRI (2.5 ± 0.2)b. 12 h – (2.7 ± 1.3)b, CRO (5.8 ± 0.6)a, PRI (2.2 ± 0,1)b; and 120 h – SIN (1.3 ± 0.2)a, CRO (0.9 ± 0.2)b, PRI (0.8 ± 0.04)b. On Day 8, all levels remained below 1 ng mL–1. In this study, P4 released concentrations differed in 3 of 15 periods in second-use device tests. In third-use device tests, Cronipres® released significantly more P4 from 2 to 12 h. It is unclear, however, if greater release of P4 in the first 24 h is advantageous, considering that Sincrogest and Primer® P4 concentrations remained above 2 ng mL–1. Additionally, it was noticed that P4 release decreased according to the number of previous uses. These findings suggest a variety of possibilities matching different device brands and different animal categories depending on animal steroid metabolism rate and consequent need for exogenous P4 supplementation. However, for such a claim, further studies on this topic are needed. Supported by FAPESP – Fundação de Amparo à Pesquisa do estado de São Paulo." @default.
- W4247258103 created "2022-05-12" @default.
- W4247258103 creator A5006487975 @default.
- W4247258103 creator A5029546653 @default.
- W4247258103 creator A5065807603 @default.
- W4247258103 creator A5084424044 @default.
- W4247258103 creator A5086305731 @default.
- W4247258103 creator A5086646288 @default.
- W4247258103 creator A5087280099 @default.
- W4247258103 date "2011-01-01" @default.
- W4247258103 modified "2023-10-12" @default.
- W4247258103 title "15 IN VIVO PROGESTERONE RELEASE KINETICS: A COMPARATIVE STUDY OF DIFFERENT INTRAVAGINAL DEVICES USED IN CATTLE" @default.
- W4247258103 doi "https://doi.org/10.1071/rdv23n1ab15" @default.
- W4247258103 hasPublicationYear "2011" @default.
- W4247258103 type Work @default.
- W4247258103 citedByCount "1" @default.
- W4247258103 countsByYear W42472581032012 @default.
- W4247258103 crossrefType "journal-article" @default.
- W4247258103 hasAuthorship W4247258103A5006487975 @default.
- W4247258103 hasAuthorship W4247258103A5029546653 @default.
- W4247258103 hasAuthorship W4247258103A5065807603 @default.
- W4247258103 hasAuthorship W4247258103A5084424044 @default.
- W4247258103 hasAuthorship W4247258103A5086305731 @default.
- W4247258103 hasAuthorship W4247258103A5086646288 @default.
- W4247258103 hasAuthorship W4247258103A5087280099 @default.
- W4247258103 hasConcept C126322002 @default.
- W4247258103 hasConcept C140793950 @default.
- W4247258103 hasConcept C16685009 @default.
- W4247258103 hasConcept C176685330 @default.
- W4247258103 hasConcept C185592680 @default.
- W4247258103 hasConcept C2777005246 @default.
- W4247258103 hasConcept C2778610407 @default.
- W4247258103 hasConcept C2779234561 @default.
- W4247258103 hasConcept C2781087480 @default.
- W4247258103 hasConcept C33923547 @default.
- W4247258103 hasConcept C54355233 @default.
- W4247258103 hasConcept C71315377 @default.
- W4247258103 hasConcept C71924100 @default.
- W4247258103 hasConcept C8264082 @default.
- W4247258103 hasConcept C86803240 @default.
- W4247258103 hasConceptScore W4247258103C126322002 @default.
- W4247258103 hasConceptScore W4247258103C140793950 @default.
- W4247258103 hasConceptScore W4247258103C16685009 @default.
- W4247258103 hasConceptScore W4247258103C176685330 @default.
- W4247258103 hasConceptScore W4247258103C185592680 @default.
- W4247258103 hasConceptScore W4247258103C2777005246 @default.
- W4247258103 hasConceptScore W4247258103C2778610407 @default.
- W4247258103 hasConceptScore W4247258103C2779234561 @default.
- W4247258103 hasConceptScore W4247258103C2781087480 @default.
- W4247258103 hasConceptScore W4247258103C33923547 @default.
- W4247258103 hasConceptScore W4247258103C54355233 @default.
- W4247258103 hasConceptScore W4247258103C71315377 @default.
- W4247258103 hasConceptScore W4247258103C71924100 @default.
- W4247258103 hasConceptScore W4247258103C8264082 @default.
- W4247258103 hasConceptScore W4247258103C86803240 @default.
- W4247258103 hasIssue "1" @default.
- W4247258103 hasLocation W42472581031 @default.
- W4247258103 hasOpenAccess W4247258103 @default.
- W4247258103 hasPrimaryLocation W42472581031 @default.
- W4247258103 hasRelatedWork W1994554879 @default.
- W4247258103 hasRelatedWork W1995145325 @default.
- W4247258103 hasRelatedWork W2076905776 @default.
- W4247258103 hasRelatedWork W2097476982 @default.
- W4247258103 hasRelatedWork W2366229059 @default.
- W4247258103 hasRelatedWork W2410272703 @default.
- W4247258103 hasRelatedWork W2418667713 @default.
- W4247258103 hasRelatedWork W2443270986 @default.
- W4247258103 hasRelatedWork W2981985604 @default.
- W4247258103 hasRelatedWork W2993561967 @default.
- W4247258103 hasVolume "23" @default.
- W4247258103 isParatext "false" @default.
- W4247258103 isRetracted "false" @default.
- W4247258103 workType "article" @default.